MASATO, ANNA

MASATO, ANNA  

Dipartimento di Biologia - DiBio  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
DOPAL-induced impairment of aSynuclein and cellular proteostasis as molecular mechanism to enhance neuronal vulnerability in Parkinson's disease. 2019 Masato, Anna - - -
Impaired dopamine metabolism in Parkinson's disease pathogenesis 2019 Masato A.Plotegher N.Bubacco L. + MOLECULAR NEURODEGENERATION - -
Metformin repurposing for parkinson disease therapy: Opportunities and challenges 2021 Agostini F.Masato A.Bubacco L.Bisaglia M. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance 2021 Giusti V.Sandre M.Tessari I.Plotegher N.Masato A.Iovino L.Battisti I.Arrigoni G.Greggio E.Bubacco L.Civiero L. + MOLECULAR NEUROBIOLOGY - -
Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease 2021 Masato, AnnaSandre, MicheleAntonini, AngeloBubacco, Luigi CURRENT NEUROPHARMACOLOGY - -
Photoresponsive Prion-Mimic Foldamer to Induce Controlled Protein Aggregation 2021 Marafon G.Masato A.Plotegher N.Bubacco L.Moretto A. + ANGEWANDTE CHEMIE. INTERNATIONAL EDITION - -
Superoxide Dismutases SOD1 and SOD2 Rescue the Toxic Effect of Dopamine-Derived Products in Human SH-SY5Y Neuroblastoma Cells. 2019 Alice BiosaFederica De LazzariMASATO, ANNARoberta FilogranaNicoletta PlotegherMariano BeltraminiLuigi BubaccoMarco Bisaglia NEUROTOXICITY RESEARCH - -
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 2022 Masato A.Frau R.Parrella E.Bubacco L. + MOLECULAR THERAPY - -
Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease: An Editorial Highlight for “Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo” 2021 Masato A.Bubacco L.Greggio E. JOURNAL OF NEUROCHEMISTRY - -